Last reviewed · How we verify

4% lidocaine topical anesthetic cream

Jenny Boucher, PharmD · FDA-approved active Small molecule Quality 5/100

4% lidocaine topical anesthetic cream is a Small molecule drug developed by Jenny Boucher, PharmD. It is currently FDA-approved. Also known as: 4% liposomal lidocaine (Brand name = LMX4).

At a glance

Generic name4% lidocaine topical anesthetic cream
Also known as4% liposomal lidocaine (Brand name = LMX4)
SponsorJenny Boucher, PharmD
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about 4% lidocaine topical anesthetic cream

What is 4% lidocaine topical anesthetic cream?

4% lidocaine topical anesthetic cream is a Small molecule drug developed by Jenny Boucher, PharmD.

Who makes 4% lidocaine topical anesthetic cream?

4% lidocaine topical anesthetic cream is developed and marketed by Jenny Boucher, PharmD (see full Jenny Boucher, PharmD pipeline at /company/jenny-boucher-pharmd).

Is 4% lidocaine topical anesthetic cream also known as anything else?

4% lidocaine topical anesthetic cream is also known as 4% liposomal lidocaine (Brand name = LMX4).

What development phase is 4% lidocaine topical anesthetic cream in?

4% lidocaine topical anesthetic cream is FDA-approved (marketed).

Related